The Methylphenidate HCl Market continues to expand as psychiatrists, pediatricians, and neurologists increasingly rely on this established psychostimulant for managing attention-deficit hyperactivity disorder, narcolepsy, and certain treatment-resistant depression presentations. With methylphenidate hydrochloride remaining one of the most prescribed medications for ADHD across both pediatric...